Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
8.50
+0.25 (3.03%)
At close: Oct 17, 2025, 4:00 PM EDT
8.18
-0.32 (-3.76%)
After-hours: Oct 17, 2025, 7:28 PM EDT
Clene Revenue
Clene had revenue of $27.00K in the quarter ending June 30, 2025, a decrease of -70.33%. This brings the company's revenue in the last twelve months to $286.00K, down -35.29% year-over-year. In the year 2024, Clene had annual revenue of $342.00K, down -47.71%.
Revenue (ttm)
$286.00K
Revenue Growth
-35.29%
P/S Ratio
247.60
Revenue / Employee
$3,763
Employees
76
Market Cap
85.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 342.00K | -312.00K | -47.71% |
| Dec 31, 2023 | 654.00K | 181.00K | 38.27% |
| Dec 31, 2022 | 473.00K | -250.00K | -34.58% |
| Dec 31, 2021 | 723.00K | 517.00K | 250.97% |
| Dec 31, 2020 | 206.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Walmart | 693.15B |
| Costco Wholesale | 275.24B |
| PepsiCo | 91.75B |
| The Procter & Gamble Company | 84.28B |
| Unilever | 70.19B |
| Anheuser-Busch InBev | 58.52B |
| The Coca-Cola Company | 47.06B |
| Philip Morris International | 39.06B |
CLNN News
- 3 days ago - Clene to Participate in a Panel Discussion at the Maxim Growth Summit - GlobeNewsWire
- 23 days ago - Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients - GlobeNewsWire
- 6 weeks ago - Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson's Disease - GlobeNewsWire
- 6 weeks ago - Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 2 months ago - Clene to Present at the Emerging Growth Conference - GlobeNewsWire
- 2 months ago - Clene to Present at the Canaccord 45th Annual Growth Conference - GlobeNewsWire
- 3 months ago - Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings - GlobeNewsWire